Crowdonomics
WatchlistPortfolio
ROSE DIAGNOSTICS

Reg CF · Class B Non-Voting Common Stock · Nov 2024

ClosedReg CFCommon Equity
via StartEngine · last checked Sep 30, 2026
Raised
$0 / $1.2M max
0% of ceiling
Investors
—
—
Post-money valuation
$15.1M
pre-money + amount raised

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$0
FY2022
$0
−$64K
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
-$63,761
Taxes paid
$0
$0
Balance sheet
Cash
$0
$5,792
Accounts receivable
$0
$0
Total assets
$0
$5,792
Short-term debt
$0
$0
Long-term debt
$0
$0
Total liabilities
$0
$0
Other
Headcount
—
1

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Nov 20, 2024
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$15M
Post-money$15.1M
Price / share$28.84
Shares offered4,299

Perks

Invest $2,000+ within the first 2 weeks | 10% bonus shares · until Nov 28, 202410% bonus$2K+

Offering details

Target$123,983
Max$1,234,986
Min investment$490
OpenedNov 15, 2024
DeadlineFeb 13, 2025
ClosedFeb 13, 2025
Days active90

Links & provenance

SEC filing
Source: SEC EDGAR
0001665160-24-001629
Last synced Sep 30, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.